We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · February 08, 2021

Staphylococcus aureus Carriage in Hidradenitis Suppurativa May Impact Response to Adalimumab

Dermatology (Basel, Switzerland)

 

Additional Info

Dermatology (Basel, Switzerland)
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab
Dermatology (Basel) 2021 Jan 05;[EPub Ahead of Print], D Stergianou, V Tzanetakou, M Argyropoulou, T Kanni, PG Bagos, EJ Giamarellos-Bourboulis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading